HER2/neu Expression in Gastric and Esophagogastric Junction Adenocarcinoma
نویسندگان
چکیده
Background: Gastric cancer is one of the most commonly diagnosed cancer and one of the most common causes of cancerrelated deaths worldwide. HER-2/neu, a well-recognized factor, is indicated in the development of certain human solid tumors, notably breast cancer. High expression of HER2/neu has correlated with poor prognosis. Studies reveal combination of treatment with antibody targeting HER-2/neu protein (Trastuzumab) and chemotherapy significantly improves overall survival in patients with gastric and esophagogastric junctional (EGJ) adenocarcinomas with HER-2/neu protein overexpression. We aimed to investigate the frequency of Her2/neu expression and association with clinicopathological parameters in our gastric and EGJ adenocarcinoma series to make a contribution to the emerging data on this oncogene. Materials and Methods: A total of 100 cases, including biopsy and resection specimens between November 2012 and December 2014, were selected. Her2/neu expression was determined by immunohistochemistry (IHC) on tumor tissues. Samples with IHC 2+ scores/equivocal cases were tested using fluorescent in situ hybridization (FISH). Result: We found 8% positivity for HER2/neu protein expression (IHC 3+ and IHC 2+/FISH +). Gene amplification in 5 cases revealed 100% concordance with IHC 3+. The findings of our study are in concordance with international data. We also observed a relationship of intestinal phenotype, EGJ tumors, and well-differentiated adenocarcinoma with HER2 overexpression. Conclusion: The findings of our study suggest a relationship of EGJ tumors, intestinal phenotype, and well-differentiated adenocarcinoma with HER2 overexpression.
منابع مشابه
HER-2/neu Marker Examination using Immunohistochemical Method in Patients Suffering from Gastric Adenocarcinoma
Gastric adenocarcinoma is the second leading cause of death due to cancer in the world and in advanced stages the prognosis is poor with current therapies. Over-expression of HER-2/neu has been seen in several cancers such as gastric cancer and its expression is associated with poor prognosis. The aim of this study is to evaluate the over-expression of HER-2/neu in gastric biopsy samples of pat...
متن کاملTemplate for Reporting Results of HER2 (ERBB2) Biomarker Testing of Specimens From Patients With Adenocarcinoma of the Stomach or Esophagogastric Junction.
متن کامل
Her2/neu testing in gastric cancer: evaluating the risk of sampling errors
BACKGROUND We evaluated the risk of sampling errors in specimens of biopsy size, which may be caused by heterogeneous overexpression of Her2/neu in gastric cancer (GC). PATIENTS AND METHODS The study cohort comprised 454 gastrectomy patients with adenocarcinoma of the stomach or esophago-gastric junction. Tissue micro-arrays (TMAs) served as 'biopsy procedure' and were generated from formalin...
متن کاملThe incidence and prognostic value of HER2 overexpression and cyclin D1 expression in patients with gastric or gastroesophageal junction adenocarcinoma in Israel
Human epidermal growth factor 2 (HER2) positivity rates for gastric or gastroesophageal junction (GEJ) adenocarcinoma have been reported at 15-25%. Cyclin D1 (BCL1) is a non-specific proliferative marker. The prognostic significance of HER2 and cyclin D1 is inconclusive, with contradictory data. The aim of this study was to evaluate the incidence of HER2 overexpression in gastric or GEJ patient...
متن کاملEvaluation of HER2/neu Expression in High-Grade Endometrial Carcinoma and Its Clinicopathological Correlation
Background & Objective: Endometrial carcinoma (EC) has been traditionally classified into two distinct categories of low-grade and high-grade. Type I (low grade) EC, which constitutes the majority of cases, is linked to estrogen-related molecular pathways. But type II (high-grade) EC accounts for 10-20% of cases and behaves in an aggressive way. Pathologic and biological featur...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2017